by admin | Jun 5, 2019
(GLOBE NEWSWIRE) — MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management and pain, announced today that it received a Notice of Allowance from the United States Patent...
by admin | Mar 13, 2018
(GLOBE NEWSWIRE) — Daré Bioscience, Inc.(NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today announced that it has entered into definitive agreements with Hammock Pharmaceuticals, Inc., TriLogic Pharma LLC and MilanaPharm LLC under which...
Recent Comments